Clean Science & Technology Limited (CSTL) has announced another significant capital infusion of ₹50 crore into its wholly owned subsidiary, Clean Fino-Chem Limited (CFCL). This latest investment, disclosed in a regulatory filing, follows previous investments and demonstrates the company's continued commitment to strengthening its speciality chemicals operations.

Latest Investment Details

The recent investment was executed through a rights issue on January 8, 2026, where CSTL subscribed to an additional 8,36,121 equity shares of Clean Fino-Chem. The transaction details are presented below:

Cumulative Investment Pattern

This marks the latest in a series of investments by CSTL in its subsidiary, with previous capital infusions documented in March 2022, October 2022, February 2024, and January 2025. The company has now invested a total of ₹120 crore across multiple tranches, including the previous ₹70 crore investment.

Clean Fino-Chem's Performance Trajectory

Clean Fino-Chem, incorporated on March 22, 2022, has demonstrated remarkable growth in the speciality chemicals sector:

Strategic Rationale

According to the regulatory disclosure, the additional capital will be primarily utilized for funding CFCL's ongoing projects. This investment strategy aligns with CSTL's objective to expand its presence in the speciality chemicals market through its subsidiary operations.

Transaction Framework

The investment maintains the established transaction structure:

• Related Party Transaction: CFCL remains a wholly owned subsidiary of CSTL
• Arm's Length Basis: The transaction was conducted at fair market terms
• Ownership Structure: CSTL continues to hold 100% ownership of CFCL
• Industry Focus: Speciality chemicals manufacturing and sales
• Consideration: 100% cash subscription to equity share capital

This continued investment underscores Clean Science & Technology Limited's strategic focus on building its speciality chemicals capabilities through Clean Fino-Chem, which has shown substantial revenue growth since its incorporation.

Clean Science & Technology has announced a significant milestone with the commencement of commercial production of hydroquinone and catechol at its manufacturing facilities. This development marks an important expansion in the company's specialty chemical manufacturing capabilities and reinforces its commitment to supporting India's import substitution goals.

Production Milestone

Clean Science & Technology has successfully started commercial production of two critical chemical compounds that serve various industrial applications. The following table outlines the key details of this production milestone:

Import Substitution Impact

The commencement of hydroquinone and catechol production represents a strategic contribution to India's import substitution initiatives. These specialty chemicals are essential components in various industrial processes, and domestic production helps reduce reliance on imported materials. The company's entry into manufacturing these compounds strengthens the domestic supply chain for critical chemical intermediates.

Market Position Enhancement

This production launch is expected to enhance Clean Science & Technology's market share in the specialty chemicals sector. The addition of hydroquinone and catechol to the company's product portfolio diversifies its manufacturing capabilities and creates new revenue streams. The company's established manufacturing expertise positions it well to serve domestic demand for these specialty chemical products.

Strategic Significance

The successful start of commercial production demonstrates the company's ability to expand its manufacturing footprint in high-value specialty chemicals. This development aligns with the broader industry trend toward domestic manufacturing of critical chemical compounds and supports the company's growth strategy in the specialty chemicals market.

The commencement of hydroquinone and catechol production not only strengthens Clean Science & Technology's import substitution efforts but also expands its market presence in the specialty chemicals industry. This strategic move is expected to contribute to the company's growth and reinforce its position in the domestic chemical manufacturing sector.